Results

Total Results: 323 records

Showing results for "malignant neoplasm".

  1. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_SEVERITY.PDF
    January 01, 2003 - electrolyte disorders 7560944 416784 0.00 1.00 0.12 0.33 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7560944 416784 0.00 1.00 0.03 0.18 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 2847 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 7057 0.09 102: NERVOUS SYSTEM NEOPLASMS W MCC … W/O CC 2931 0.04 821: RESPIRATORY NEOPLASMS W CC 15790 0.20 822: RESPIRATORY NEOPLASMS W MCC 7482 … DEN02: Dental Disease 1622 0.02 DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
  2. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_SEVERITY.PDF
    January 01, 2004 - electrolyte disorders 8004571 0 0.00 1.00 0.13 0.34 CM_METS : AHRQ comorbidity measure: Metastatic cancer … comorbidity measure: Renal failure 8004571 0 0.00 1.00 0.04 0.19 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 2892 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 7644 0.10 102: NERVOUS SYSTEM NEOPLASMS W MCC … W/O CC 2755 0.03 821: RESPIRATORY NEOPLASMS W CC 15940 0.20 822: RESPIRATORY NEOPLASMS W MCC 8116 … Parotitis or Benign Tumors 2908 0.04 DEN04: Gingival and Periodontal Disease 813 0.01 DEN05: Neoplasm
  3. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
    January 01, 2005 - electrolyte disorders 7995048 0 0.00 1.00 0.14 0.35 CM_METS : AHRQ comorbidity measure: Metastatic cancer … comorbidity measure: Renal failure 7995048 0 0.00 1.00 0.04 0.20 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … WO CC 2805 0.04 101: NERVOUS SYSTEM NEOPLASMS W CC 7642 0.10 102: NERVOUS SYSTEM NEOPLASMS W MCC 1733 … WO CC 2478 0.03 821: RESPIRATORY NEOPLASMS W CC 15629 0.20 822: RESPIRATORY NEOPLASMS W MCC 8705 0.11 … Parotitis or Benign Tumors 3040 0.04 DEN04: Gingival and Periodontal Disease 780 0.01 DEN05: Neoplasm
  4. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Severity.PDF
    January 01, 2008 - electrolyte disorders 8,158,381 0 0.00 1.00 0.16 0.37 CM_METS : AHRQ comorbidity measure: Metastatic cancer … Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_TUMOR : AHRQ comorbidity measure: Solid tumor … WO CC/MC 2,807 0.03% 541: NERVOUS SYSTEM NEOPLASMS W CC 5,601 0.07% 542: NERVOUS SYSTEM NEOPLASMS … WO CC/MC 2,034 0.02% 1801: RESP NEOPLASMS W CC 12,477 0.15% 1802: RESP NEOPLASMS W MCC 9,933 0.12% … DEN02: Dental Disease 2,083 0.03% DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
  5. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Severity.PDF
    January 01, 2009 - electrolyte disorders 7,810,762 0 0.00 1.00 0.17 0.38 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,810,762 0 0.00 1.00 0.08 0.28 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … WO CC/MC 2,263 0.03% 541: NERVOUS SYSTEM NEOPLASMS W CC 4,929 0.06% 542: NERVOUS SYSTEM NEOPLASMS … WO CC/MC 1,619 0.02% 1801: RESP NEOPLASMS W CC 11,043 0.14% 1802: RESP NEOPLASMS W MCC 9,301 0.12% … DEN02: Dental Disease 2,013 0.03% DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
  6. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Severity.PDF
    January 01, 2009 - electrolyte disorders 3,407,146 0 0.00 1.00 0.07 0.26 CM_METS : AHRQ comorbidity measure: Metastatic cancer … Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_TUMOR : AHRQ comorbidity measure: Solid tumor … WO CC/MC 456 0.01% 541: NERVOUS SYSTEM NEOPLASMS W CC 508 0.01% 542: NERVOUS SYSTEM NEOPLASMS W MCC … WO CC/MC 63 0.00% 1801: RESP NEOPLASMS W CC 143 0.00% 1802: RESP NEOPLASMS W MCC 48 0.00% 1830: MAJ … DEN02: Dental Disease 1,817 0.05% DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
  7. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Severity.PDF
    January 01, 2007 - electrolyte disorders 8043415 0 0.00 1.00 0.16 0.36 CM_METS : AHRQ comorbidity measure: Metastatic cancer … comorbidity measure: Renal failure 8043415 0 0.00 1.00 0.07 0.26 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … WO CC/MC 813 0.01 541: NERVOUS SYSTEM NEOPLASMS W CC 1448 0.02 542: NERVOUS SYSTEM NEOPLASMS W MCC … WO CC/MC 16397 0.20 1801: RESP NEOPLASMS W CC 19542 0.24 1802: RESP NEOPLASMS W MCC 6472 0.08 1820 … DEN02: Dental Disease 1986 0.02 DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
  8. hcup-us.ahrq.gov/reports/natstats/93drgb.htm
    September 01, 1997 - Kidney, ureter & major 35,969 0.10 10.70 24,365 bladder procedures for neoplasm … ureter & major 35,953 0.10 9.72 20,738 bladder procedures for non-neoplasm … ureter & major 22,447 0.06 4.72 10,378 bladder procedures for non-neoplasm … 2.57 3,811 318 Kidney & urinary tract 11,640 0.03 7.50 10,707 neoplasms … CC 319 Kidney & urinary tract 1,664 0.00 3.74 5,891 neoplasms
  9. hcup-us.ahrq.gov/reports/natstats/94drgb.htm
    September 01, 1997 - , ureter & major 35,918 0.10 9.78 24,304 bladder procedures for neoplasm … 4.10 5,991 318 Kidney & urinary tract 11,455 0.03 7.16 10,533 neoplasms … w/ CC 319 Kidney & urinary tract 1,274 0.00 3.14 5,173 neoplasms w/ … 8,040 0.02 11.79 31,502 disorders or poorly differentiated neoplasm … 2,264 0.01 4.56 12,478 disorders or poorly differentiated neoplasm
  10. Table 1 (pdf file)

    hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/TableofChanges2018_1.pdf
    January 01, 2018 - remission DRUG F1911 Other psychoactive substance abuse, in remission DRUG C9620 Malignant mast cell neoplasm … Aggressive systemic mastocytosis LYMPH C9622 Mast cell sarcoma LYMPH C9629 Other malignant mast cell neoplasm
  11. hcup-us.ahrq.gov/toolssoftware/ccs/CCSCategoryNames_FullLabels.pdf
    October 07, 2016 - myeloma 41 Cancer; other and unspecified primary 42 Secondary malignancies 43 Malignant neoplasm without … Other secondary malignancy 2.13 Malignant neoplasm without specification of site [43] 2.14 Neoplasmsneoplasms 2.16.1 Benign neoplasm of uterus [46] 2.16.2 Other and unspecified benign neoplasm [47] 2.16.2.1 … Benign neoplasm of ovary 2.16.2.2 Benign neoplasm of colon 2.16.2.3 Benign neoplasm of the thyroid 2.16.2.4 … Benign neoplasm of cerebral meninges 2.16.2.5 Other and unspecified benign neoplasms 3 Endocrine; nutritional
  12. hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_4_3.jsp
    January 01, 2006 - 3.5 18,027 Thyroid disorders 2.7 18,032 Epilepsy, convulsions 3.6 18,074 Benign … endocrine, and metabolic disorders 3.6 31,256 Digestive congenital anomalies 5.9 31,655 Malignantneoplasm without specification of site 7.6 31,798 Other benign neoplasm 4.4 31,832 … conditions 7.4 33,152 Paralysis 7.6 33,230 Chronic renal failure 5.3 33,422 Neoplasms … of other urinary organs 6.2 38,019 Secondary malignancies 7.1 38,140 Osteoarthritis
  13. hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-vs-Beta-CCS-Comparison.pdf
    January 01, 2020 - NEO070 Secondary malignancies 6 6 0 43 Malignant neoplasm without specification of site NEO071 Malignantneoplasm, unspecified 10 9 1 47 Other and unspecified benign neoplasm NEO073 Benign neoplasms 9 1 … NEO070 – Secondary malignancies 43 Malignant neoplasm without specification of site 3 NEO066 – Malignant … neoplasm of uterus 1 NEO073 – Benign neoplasms 47 Other and unspecified benign neoplasm 3 NEO073 – … Benign neoplasms 48 Thyroid disorders 3 END001 – Thyroid disorders 49 Diabetes mellitus without complication
  14. hcup-us.ahrq.gov/reports/statbriefs/sb22.jsp
    January 22, 2007 - Hospital stays for cervical cancer and all female-specific cancers had comparable lengths of stay (3.7 … Malignant neoplasm of cervix uteri (endocervix) – 180.1 Malignant neoplasm of cervix uteri (exocervix … ) – 180.8 Malignant neoplasm of cervix uteri (other specified sites of cervix) – 180.9 Malignant … Hospital stays for cervical cancer compared with hospital stays for all female-specific cancers, 2004 … *   Hospital stays for cervical cancer Hospital stays for all female-specific cancers Number
  15. hcup-us.ahrq.gov/reports/statbriefs/sb22.pdf
    January 01, 2007 - Hospital stays for cervical cancer and all female-specific cancers had comparable lengths of stay (3.7 … Malignant neoplasm of cervix uteri (endocervix) – 180.1 Malignant neoplasm of cervix uteri (exocervix … ) – 180.8 Malignant neoplasm of cervix uteri (other specified sites of cervix) – 180.9 Malignant neoplasm … Hospital stays for cervical cancer compared with hospital stays for all female-specific cancers, 2004 … * Hospital stays for cervical cancer Hospital stays for all female-specific cancers Number
  16. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_Core_Weighted.PDF
    January 01, 2020 - W MCC 32,499 0.10% 180: RESPIRATORY NEOPLASMS WITH MCC 10,248 0.03% 181: RESPIRATORY NEOPLASMS W CC … 16,395 0.05% 181: RESPIRATORY NEOPLASMS WITH CC 5,009 0.02% 182: RESPIRATORY NEOPLASMS W/O CC/MCC … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 5,231 0.02% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … & URETER PROCEDURES FOR NON-NEOPLASM W CC 44,512 0.14% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM … TRACT NEOPLASMS W CC 3,962 0.01% 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH CC 1,357 0.00% 688:
  17. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core_Weighted.PDF
    January 01, 2022 - WITH MCC 113 0.00% 181: RESPIRATORY NEOPLASMS WITH CC 110 0.00% 182: RESPIRATORY NEOPLASMS WITHOUT … WITH MCC 116 0.00% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 356 0.01% 658: KIDNEY AND … URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 224 0.00% 659: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM … WITH MCC 463 0.01% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 2,320 0.04% 661: KIDNEY … AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC 3,665 0.06% 662: MINOR BLADDER PROCEDURES WITH
  18. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2022_Core_Weighted.PDF
    January 01, 2022 - WITH MCC 6,519 0.02% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 20,880 0.06% 658: KIDNEY … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 19,551 0.06% 659: KIDNEY AND URETER PROCEDURES FOR … NON-NEOPLASM WITH MCC 26,214 0.08% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 63,128 … 0.19% 661: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC 60,251 0.18% 662: MINOR BLADDER … IMMUNOLOG DISORD 411,875 1.25% 17: MYELOPROLIFERATIVE DISEASES & DISORDERS, POORLY DIFFERENTIATED NEOPLASM
  19. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2018_IP_MaskedStats.PDF
    January 01, 2018 - W MCC 9,775 0.19 181: RESPIRATORY NEOPLASMS W CC 5,616 0.11 182: RESPIRATORY NEOPLASMS W/O CC/MCC … & URETER PROCEDURES FOR NON-NEOPLASM W CC 3,699 0.07 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … W MCC 902 0.02 687: KIDNEY & URINARY TRACT NEOPLASMS W CC 1,324 0.03 688: KIDNEY & URINARY TRACT NEOPLASMS … W MCC 9,778 0.19 181: RESPIRATORY NEOPLASMS W CC 5,616 0.11 182: RESPIRATORY NEOPLASMS W/O CC/MCC … & URETER PROCEDURES FOR NON-NEOPLASM W CC 3,700 0.07 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM
  20. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2017_IP_MaskedStats.PDF
    January 01, 2017 - W MCC 8,341 0.18 181: RESPIRATORY NEOPLASMS W CC 5,401 0.11 182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 62 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 587 0.01 660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 1,632 0.03 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … FOR NEOPLASM W/O CC/MCC 62 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 590 0.01 660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 1,631 0.03 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: